Apart from classical antigen-presenting cells (APCs) like dendritic cells and macrophages, there are semiprofessional APCs such as endothelial cells (ECs) and Langerhans' cells. Human cytomegalovirus (HCMV) infects a wide range of cell types including the ECs which are involved in the trafficking and homing of T cells. By investigating the interaction of naïve T cells obtained from HCMV-seronegative umbilical cord blood with autologous HCMV-infected human umbilical vein ECs (HUVECs), we could show that the activation of naïve T cells occurred after 1 day of peripheral blood mononuclear cell (PBMC) exposure to HCMV-infected HUVECs. The percentage of activated T cells increased over time and the activation of naïve T cells was not induced by either autologous uninfected HUVECs or by autologous HCMV-infected fibroblasts. The activation of T cells occurred also when purified T cells were co-cultured with HCMV-infected HUVECs. In addition, in most of the donors only CD8 + T cells were activated, when the purified T cells were exposed to HCMV-infected HUVECs. The activation of naïve T cells was inhibited when the NKG2D receptor was blocked on the surface of T cells and among the different NKG2D ligands, we identified two ligands (ULBP4 and MICA) on HCMV-infected HUVECs which might be the interaction partners of the NKG2D receptor. Using a functional cell culture assay, we could show that these activated naïve T cells specifically inhibited HCMV transmission. Altogether, we identified a novel specific activation mechanism of naïve T cells from the umbilical cord by HCMV-infected autologous HUVECs through interaction with NKG2D.
INTRODUCTION
Umbilical cord blood (UCB) is used as a source of haematopoietic stem cells for transplantation having advantages compared with bone marrow stem cells like easy availability, lower risk of transmitting infections and less stringent human leukocyte antigen matching [1, 2] . UCB transplantation is used to treat patients who are affected by many haematologic and non-haematologic disorders [3] . Limitations of using UCB are low counts of stem cells and delayed immune reconstitution [4, 5] . Since most of the immune cells are completely naïve in UCB, there is no transfer of protective memory immune cells which are important for controlling viral infections. Viral infections caused by human cytomegalovirus (HCMV), BK virus, respiratory viruses and Epstein-Barr virus are a major problem in UCB transplant recipients due to posttransplant immune deficiency [5, 6] . HCMV, a member of the beta herpesvirus family, is the most common opportunistic pathogen, occurring in 20-60 % of transplant recipients [7, 8] . The improved detection, the antiviral prophylaxis and the pre-emptive therapy can be credited for keeping the HCMV infection under control in transplant recipients [9, 10] . HCMV is also the most often infectious cause leading to congenital diseases after infection in utero [11, 12] . Methods to control this important infectious problem are open, although different strategies are under investigation [13, 14] .
It is generally believed that the immune cells from cord blood are immature since most of these cells are naïve and respond to stimulation by secreting low amounts of cytokines (e.g. IL-2) compared to adult cells [15, 16] . However, it was shown recently that 50 % of CD4 + T cells from human neonates can produce IL-8 [17] . This is a significantly higher percentage than in adults. Some groups also showed that the cord blood (CB) T cells produce similar amounts of IL-2 and IL-4 but lower amounts of IFN-g and TNF-a than adult T cells [18, 19] . Taken together, it is reasonable to postulate that the naïve neonatal T cells are distinct from adult naïve T cells.
The classical antigen-presenting cells (APCs) required for priming the naïve T cells to become antigen-specific T cells are dendritic cells, B cells and macrophages [20] [21] [22] . Apart from classical APCs, there are semiprofessional APCs like endothelial cells (ECs), Langerhans' cells and mesangial cells [23] [24] [25] [26] [27] . ECs, which line the blood vessels, and play an important role in the trafficking and homing of T cells. It is believed that the antigen-specific T cells can transmigrate to the site of infection by interacting with ECs, whereas the naïve T cells cannot adhere to the ECs and therefore cannot migrate to the site of infection [28, 29] . The difference is due to the specific pattern of receptor expression on the different types of T cells and their interaction with specific ligands on EC [29, 30] .
The priming of CD8 + naïve T cells through cross-presentation of soluble antigens by liver sinusoidal ECs [31] [32] [33] has been shown in the mouse system. ECs which have been postulated to function as semiprofessional APCs [24-26, 34, 35] are permissive for HCMV infection [36, 37] . The aim of our study was to reveal, in the human system, the functional relevance of the interaction between naïve T cells and HCMV-infected ECs and to answer the following questions which arise with respect to naïve T cells: (1) Can naïve T cells become activated after exposure to HCMV-infected human umbilical vein ECs (HUVECs)? (2) Are such activated T cells functionally active against HCMV? (3) Which population among the CD3 + T cells becomes activated on exposure to HCMV-infected HUVECs? (4) What could be the mechanism of activation of naïve T cells by HCMVinfected HUVECs?
In order to study the interaction between in vitro-infected ECs and naïve T cells from HCMV-seronegative donors in a completely autologous system, we used T cells and HUVECs from the same umbilical cords. We investigated the activation of CB naïve T cells in vitro both in the presence and absence of APCs. Furthermore, autologous human umbilical Wharton's jelly fibroblasts (HUWFs) were used as a control to verify whether the stimulatory effect for naïve T cells was specifically by HUVECs or a general property of neonatal T cells. The specificity of these activated naïve T cells for HCMV infection was verified by a functional assay. We finally identified the mechanism through which the naïve T cells were activated after exposure to HCMV-infected HUVECs.
RESULTS
The autologous system to analyse the activation of naïve T cells In order to provide a relevant completely autologous system, the immune effector cells [peripheral blood mononuclear cells (PBMCs) and purified T cells] as well as the target cells (HUVECs and HUWFs) were isolated from the same umbilical cord (Fig. S1 , available in the online version of this article). The target cells were either left uninfected or were infected by cell-free HCMV (TB40/E) to reach a 100 % infection rate (IR) as measured by immediate early antigen IE1-2 expression (IEA). The immune effector cells were cocultured with the target cells without any cytokine addition for 1, 3, 7 and 14 days. Then, they were collected and stained for the expression of surface markers like CD3 (T cell), CD45RA (naïve immune cell) and CD69 (activation marker) as well as the expression of intracellular IFN-g and IL-2. CD69 was expressed very early during the activation process on T cells [38, 39] . IFN-g and IL-2 are the cytokines released by activated and effector T cells [40, 41] . It is generally accepted that T cells from UCB are mostly naïve [15] . Since antigen-specific T cells cannot cross the placental barrier and all mothers were HCMV-seronegative, CD3 and CD45RA staining is suitable to identify the naïve T cells. We also confirmed the naïve nature of T cells by using various markers (Fig. S2b) . T cells from seronegative donors were mostly naïve (more than 95 %) which was identified by the expression of naïve T cell markers CD45RA, CD62L and CCR7. T cells from seropositive donors were taken as controls.
Activation of naïve T cells depends on the IR of the target cells
To study the activation of naïve T cells by the ECs, PBMCs obtained from the CB of HCMV-seronegative donors were co-cultured with autologous HUVECs infected with increasing doses of HCMV to yield 10 , 45 or 90 % IRs. As shown in Fig. 1 , after 24 h of co-culture, approximately 7 % of naïve T cells expressed CD69 when exposed to HUVECs with 90 % IR. The percentage of activated naïve T cells decreased to around 5 and 2 %, when using HUVECs with lower IRs of 45 and 10 %. Only around 1 % of T cells were activated when PBMCs were exposed to uninfected HUVECs. Stimulation by phorbol myristate acetate (PMA) and ionomycin activated approximately 80 % of the T cells. These two conditions served as negative and positive controls of the assay. The percentage of naïve T cells secreting IL-2 and IFN-g  (CD3   +   IL-2 + and CD3 + IFN-g + ) after exposure to HCMVinfected HUVECs was low, yet showed a dose response correlation to the IRs of HUVECs (Fig. 1a , second and third column). The activation of naïve T cells on exposure to 90 % of infected HUVECs is significantly higher when compared with uninfected HUVECs determined by both CD69 and IFN-g (Fig. 1b) . In summary, naïve CB T cells were activated when PBMCs were exposed to HCMV-infected HUVECs for 24 h and the degree of activation depended on the number of HCMV-infected HUVECs. Kinetics of naïve T cell activation To determine whether the activation of CB naïve T cells increases over time, we performed activation kinetic analyses (days 1, 3, 7 and 14). To analyse both the CD4 + and CD8 + subpopulations among the CD3 + population within the constraints of our four-colour flow cytometer [42] , we used PerCP-Cy5.5-conjugated antibodies against CD4 and the CD3 at different dilutions (1 : 2 and 1 : 20 respectively). CD3 + CD4 + cells were conjugated with significantly higher numbers of antibody molecules per cell and therefore, were distinguishable from the CD3 + CD4 À cells. The gating strategy is shown in Fig. S2(a) . The lymphocytes were gated first on the basis of their side-scatter and then on the basis of CD3/CD4 and CD45RA expressions. The two subsets identified by this approach shown in Fig. S2 As shown in Fig. 2(a) , the percentage of CD3 + CD69
+ -activated T cells after exposure to HCMV-infected HUVECs increased over time doubling every 3-4 days and reaching the maximum level of approximately 50 % within 2 weeks of PBMCs co-culture with HCMV-infected HUVECs. A similar increase in percentage was not observed in the negative control where PBMCs were co-cultured with uninfected HUVECs (Fig. 2a, graph) thus indicating that the T cell activation was dependent on HCMV infection. When CD4 + and CD8 + T cell populations were analysed individually, the activation of both subpopulations increased over time (Fig. 2b) . Dot plots of naïve and non-naïve T cell populations after exposure to HCMV-infected HUVECs are shown in Fig. 2 (c). The decrease and increase in the naïve (CD45RA + ) and non-naïve T cell populations (CD45RA À ) on exposure to HCMV-infected HUVECs is shown in the graph (Fig. 2c,  right) . T cells remained generally naïve until day 3 after exposure to infected HUVECs (Fig. 2c) . CD45RA
À cells appeared by day 7, indicating two distinct (naïve and nonnaïve T cell) populations. These two T cell populations were analysed by CD69 and IFN-g on different days for the percentage of activated T cells as shown in Fig. 2d . As expected, the activation of the non-naïve T cell population observed through CD69 (Fig. 2d, left) and IFN-g (Fig. 2d, right) was more pronounced than that of naïve T cell populations. Taken together, co-culture of PBMCs with autologous HCMV-infected HUVECs resulted in a time-dependent increase in the percentage of activated T cells.
Mechanism of naïve T cell activation
Since T cells were completely naïve only until day 3, we focused on day 3 in subsequent experiments. In order to verify whether the APCs are required for the activation of naïve T cells, we co-cultured either PBMCs or naïve T cells purified from the same PBMCs with HCMV-infected and uninfected HUVECs without any cytokine addition. As shown in Fig. 3(a) , naïve T cells acquired an activated phenotype (CD3 + CD69 + ) when using PBMCs (containing APCs) or purified T cells (lacking APCs) on co-culture with HCMV-infected HUVECs, but not with uninfected HUVECs (Fig. 3a, right column) . The percentage of activated T cells was however higher (7 %) when PBMCs containing accessory cells were co-cultured with HCMVinfected HUVECs as compared to purified T cells alone (3 %). The activation of naïve T cells both in the presence and absence of APCs on exposure to HCMV-infected HUVECs was significantly higher than on exposure to uninfected HUVECs (Fig. 3c ).
To verify whether direct contact between the naïve T cells and HCMV-infected HUVECs is required for activation, PBMCs or purified naïve T cells were exposed to HCMVinfected or uninfected HUVECs either in a transwell system or directly. As shown in Fig. 3(a, b) , naïve T cells were activated both in the presence and absence of APCs only on direct contact with HCMV-infected HUVECs. Activation was strongly reduced when there was no direct contact with the infected HUVECs.
When cytotoxic CD8
+ and helper CD4 + T cell populations were analysed individually (Fig. 3d , lower row), it could be seen that only the CD8 + T cell population got activated when purified T cells were exposed to HCMV-infected HUVECs. However, when using PBMCs, (Fig. 3d , upper row), both CD4 + and CD8 + T cell populations were activated.
In addition to CD69, which is considered to be an early activation marker, we also used other T cell activation markers like CD71, OX40 and CD40L. As shown in Fig. S3 , the percentage of T cell activation analysed by either CD69 or all combined activation markers (same fluorochrome) gave comparable results, demonstrating that neonatal T cells underwent a complete activation upon encountering HCMV-infected HUVECs.
Thus, naïve T cells are activated both in the presence and absence of APCs when they are in direct contact with HCMV-infected HUVECs.
Activation of naïve T cells after exposure to infected autologous fibroblasts
To verify whether the activation of naïve T cells is specifically induced by HCMV-infected ECs (HUVECs), Error bars represent the SD of data from three different donors. Asterisks indicate the significant differences (two-way ANOVA Bonferroni post-test; *P-value <0.05 and ***P-value <0.001). autologous fibroblasts (HUWFs) were also infected and used in parallel experiments as target cells.
As shown in Fig. 4 , PBMCs or purified naïve T cells were co-cultured with HCMV-infected and uninfected HUVECs and HUWFs. The activation of naïve T cells occurred only upon exposure of PBMC (Fig. 4a) or purified naïve T cells (Fig. 4b) to HCMV-infected HUVECs, but not to infected HUWFs. When PBMCs or purified naïve T cells were exposed to uninfected HUVECs or HUWFs, there was no T cell activation. As shown in Fig. 4(c) , the activation of T cells was significantly higher only when PBMCs or purified T cells were exposed to HCMV-infected HUVECs when compared to their exposure to uninfected HUVECs.
When CD4
+ and CD8 + T cells were analysed individually, the activation of the CD8 + T cell population was higher than CD4 + T cells, when PBMCs or purified T cells were exposed to HCMV-infected HUVECs (Fig. S4a, b) which is in accordance with previous results. We also analysed the activation of CD4 + and CD8 + T cell populations on exposure to infected and uninfected HUWFs as shown in Fig. S4  (c, d ). There were no major differences found on the activation of CD4 + and CD8 + T cell population on exposure to HUWFs.
Altogether these data indicate that the activation of naïve T cells was specific only for HCMV-infected HUVECs.
Inhibition of HCMV transmission by activated naïve T cells
To verify whether the activated naïve T cells inhibit HCMV transmission, we used our previously described transmission kinetic assay (TKA) [43] .
To explain the TKA in brief: 100 % of infected cells are titrated by a fourfold dilution to give different numbers of infecting cells (640, 160 and 40) which are added to a constant number of uninfected cells (20 000) resulting in different ratios of infected cells (3.2, 0.8 and 0.2 %). After 3 days of incubation, the percentages of infected cells were determined by FACS after IEA staining. These percentages linearly correlated with the percentages of seeded infecting cells on day 0. A linear equation (y=mx+c, m=slope and c=con-stant) was used to determine the slope. It is important to use the slope values calculated for different percentages of infecting cells since the transmission kinetic value thereby becomes independent on the exact number of seeded infecting cells in different experiments. We have shown previously that the TKA can also be used to determine the inhibition of HCMV transmission by various immune interventions [43] . Here we used the TKA to study the inhibitory effect of different naïve T cell preparations on HCMV transmission. In the presence of purified B cells (negative control), HCMV transmission was essentially unaffected (2.9 % inhibitory effect) on comparison with the absence of an intervention. On the other hand, anti-HCMV neutralizing antibodies (positive control) or T cells stimulated with IL-2 induced the strongest reduction of transmission (55 and 52.5 % inhibition, respectively; P<0.001 as compared to no intervention). Purified naïve T cells as well as naïve T cells exposed to uninfected HUVECs for 3 days (in the presence or absence of APCs) did not significantly reduce HCMV transmission (approximately 14 % inhibition; P>0.05 as compared to no intervention). Naïve T cells activated both in the presence or absence of APCs upon exposure to HCMV-infected HUVECs for 3 days showed a significant reduction of transmission as compared to no intervention (41 %, 38.2 % inhibition, respectively; P<0.05 respectively). Slopes of each intervention and the quantifications of their inhibitory effects on transmission are shown in Table 1 .
It has been shown that the antigen-specific T cells control the infection through granzyme-B and IFN-g [44] . Therefore, we analysed granzyme-B and IFN-g in the supernatant of all the different T cell preparations from three donors (from Fig. 5a ) used in the TKA. As shown in Fig. 5(b) , IFN-g secretion was 70 pg ml À1 when the T cells were stimulated with IL-2. Naïve T cells which were activated both in the presence or absence of APCs for 3 days after exposure to HCMV-infected HUVECs secreted around 50 pg ml À1 granzyme-B. Naïve T cells without any previous exposure to HCMV secreted very low amounts of granzyme-B and IFN-g.
In order to identify whether CD4 + T cells or CD8 + T cells controlled the transmission, we co-cultured the isolated CD4 + and CD8 + T cells from PBMC with HCMV-infected HUVECs or uninfected HUVECs for 3 days. TKA was again performed using these isolated activated CD4 + and CD8 + T cells. As shown in Fig. 5(c) , the activated CD8 + T cell population controlled the HCMV transmission better than the CD4 + T cells. The inhibition exerted by activated CD8 + T cells was even more potent than the positive control (HCMV antibodies). This could be due to the higher absolute number of activated CD8 + T cells in the assay.
Staining and blocking of the NKG2D receptor on naïve T cells In order to identify the mechanism responsible for the activation of naïve T cells induced by HCMV-infected HUVECs, we first investigated the role of innate-like T cells: gamma delta T (gdT) and natural killer T (NKT) cells. Since the percentage of gdT and NKT cell populations among the activated naïve T cell population on exposure to HCMVinfected HUVECs was lower in comparison with the CD8 + T cell population (Fig. S5) , we analysed the relevance of activating the NKG2D receptor. NKG2D is expressed on NK cells, CD8 + T and gamma delta gdT cells [45] . When the umbilical cord CD4 + and CD8 + T cell populations from the seronegative donors were stained for NKG2D expression, more than 90 % of CD8 + T cell population expressed NKG2D, whereas very few CD4 + T cells expressed NKG2D (Fig. S6 ).
As shown in Fig. 6(a, b) In order to define whether the activation of naïve T cells depended on NKG2D, PBMCs and isolated T cells were treated with NKG2D-blocking antibodies for 30 min before they were co-cultured with HCMV-infected and uninfected HUVECs. As shown in Fig. 6(c, e) , the activation of naïve T cells when using PBMCs for co-culture with HCMVinfected HUVECs was strongly reduced by blocking NKG2D. When using isolated T cells, the activation was completely inhibited by blocking NKG2D, as shown in Fig. 6(d, e) . The few T cells that became activated by exposure to uninfected HUVECs were predominantly NKG2D-positive (Fig. 6a, b) , but their numbers were not suppressed by NKG2D blocking (Fig. 6c-e) .
CD8
+ and CD4 + T cell populations were analysed individually in the presence and absence of NKG2D-blocking antibodies as shown in Fig. S7 . The CD8 + T cells which were activated in the absence of blocking antibodies on exposure to HCMV-infected HUVECs were completely inhibited both in the presence and absence of APCs (Fig. S7a, b) .
In summary, NKG2D-blocking antibodies could significantly inhibit the activation of naïve T cells induced by the HCMV-infected HUVECs (Fig. 6e) . Thus demonstrating that NKG2D signalling is critical in the activation of naïve CB-derived T cells by co-culture with HCMV-infected HUVECs.
Staining the NKG2D ligands on ECs and fibroblasts
In order to identify the ligands of the NKG2D receptor that could trigger naïve T cell activation, we investigated the expression of ULBP1, 2, 4, 5, 6, MICA and MICB on both HCMV-infected, uninfected HUVECs and HUWFs. As shown in Fig. 7 , there was no difference in ULBP1, 2, 5, 6 and MICB expressions in infected and uninfected HUVECs. In contrast, HCMV-infected HUVECs upregulated ULBP4 within 2 days of infection, whereas uninfected HUVECs did not express ULBP4. Although uninfected HUVECs express MICA, HCMV-infected HUVECs do not downregulate MICA completely. When these ligands were analysed on HUWFs, none were upregulated on infected cells as shown in Fig. 7 .
From this data, we can conclude that ULBP4 and MICA expressed on HCMV-infected HUVECs could be the interacting partners for the NKG2D receptor expressed on naïve CD8 + T cells.
DISCUSSION
Cytomegalovirus belonging to the Herpesviridae family has evolved alongside humans resulting in an intricate balance of latency, immune evasion, reactivation and immune control [46, 47] . T cells which are the main effector cells to control HCMV infection have to undergo priming from naïve to antigen-specificity [48] [49] [50] [51] . The antigen-specific T cells from HCMV-seropositive donors can be activated within a short time after exposure to the same pathogen both in vitro and in vivo [52, 53] . The professional APCs, especially DCs and macrophages, are capable of activating and priming the T cells through MHC and TCR (T cell receptor) interaction [20, 21] . Some studies show that B cells can also act as APCs to activate and support the proliferation of T cells [22] . The so-called semiprofessional antigen-presenting ECs, which also play a major role in vivo for the trafficking of T cells to reach the site of infection, exhibit different characteristics depending on their place of origin [24, 35, 54, 55] . The activation of T cells by the ECs from liver and lymph nodes has been shown in mice [31, 32, 56] .
In order to study a potential in vitro activation of naïve T cells by ECs in humans, we had to establish a test system fulfilling two prerequisites. Effector and target cells had to be derived from HCMV-seronegative donors and the system had to be completely autologous to prevent allogeneic stimulation. We decided to use effector and target cells from the umbilical cord as this is the only realistic system to study this in humans. An additional advantage of using umbilical vein ECs as target cells is that they can easily be infected by HCMV wild-type strains. ECs from the umbilical vein have been well characterized. Studies show that HUVECs secrete a wide variety of cytokines and they express different adhesion molecules (VCAM-1, ICAM-1) and receptors (vascular endothelial growth receptor, thrombin receptor) [24, [57] [58] [59] .
In our study we could show that the in vitro activation of naïve T cells by HCMV-infected ECs happened even in the absence of classical APCs, but the activation percentage was higher in the presence of classical APCs. Activation of naïve T cells was only achieved specifically by HCMV-infected HUVECs and neither by uninfected HUVECs nor by infected autologous fibroblasts. This proves that the activation was both HCMV-and EC-specific. Transwell experiments were done to verify whether the infected HUVECs could release exosomes containing antigens to activate the T significant variance in the group (P-value <0.0001). The t-test was performed as a post hoc test to examine the significance of T cell activation on exposure to infected and uninfected HUVECs. P-values for the activation of T cells when PBMCs were exposed to HCMVinfected in comparison with uninfected HUVECs were 0.0002 (***) and 0.0016 (**) for the activation when isolated T cells were exposed to HCMV-infected in comparison with uninfected HUVECs. Error bars represent the SD of data from five different donors. (d) The activation of CD4 + and CD8 + T cell subpopulations when PBMCs (upper row) or purified T cells (lower row) were exposed to HCMV-infected HUVECs is shown.
cells [60] . But the activation of T cells happened only on direct exposure to HCMV-infected HUVECs. Some activation also happened when PBMCs were kept separate in transwell and exposed to both HCMV-infected and uninfected HUVECs indirectly. This might be due to the influence of the plastic adherence of cells [61] . The system was used without any addition of recombinant cytokines since the exact concentration of cytokine secretion in vivo is unknown and therefore the concentration of recombinant cytokines added in an in vitro system always remains questionable.
After having shown that the activation of T cells occurred only on exposure to HCMV-infected HUVECs, two . A one-way ANOVA test was first used which gave significant variance in the group (P-value <0.0001). The t-test was performed as a post hoc test to examine the significance of the activation of T cells. P-values for the activation of T cells when PBMCs were exposed to HCMV-infected in comparison with uninfected HUVECs were 0.0066 (**) and 0.0006 (***) for the activation of T cells when isolated T cells were exposed to HCMV-infected in comparison with uninfected HUVECs. Error bars represent the SD of data from three different donors. (2) What is the activation mechanism of naïve T cells? In order to answer the first question, we performed a sensitive functional assay where we found the reduction in the HCMV transmission by activated naïve T cells. Although there was a difference in the percentage of naïve T cell activation on exposure to HCMV-infected HUVECs in the presence (7 %) or absence (3 %) of APC, the inhibitions of virus transmission by both cell preparations (PBMCs or purified naïve T cells) were quite the same. Our hypothesis is that the difference seen in the percentage of activated T cells in the presence or absence of APCs might not be enough to see the differences in the reduction of HCMV transmission. The reduction in HCMV transmission by the activated T cells was correlated to their granzyme-B secretion which was negative for the other T cell preparations, indicating that the activated naïve T cells now behaved like effector T cells.
Concerning the two main subpopulations of T cells, the percentage of activated CD8 + T cells was higher than the percentage of activated CD4
+ T cells when PBMCs were exposed to HCMV-infected HUVECs. Also, when purified T cells were exposed to HCMV-infected HUVECs in the absence of classical APCs, mainly CD8 + T cells were activated and controlled the transmission. Although CD8 + T cells which were exposed to HCMV-infected HUVECs for 3 days controlled to a higher extent than other interventions, the CD8 + T cells which were exposed to uninfected HUVECs for 3 days before TKA also controlled the transmission to some extent. Since the T cells can get activated within 24 h of exposure to HCMV-infected HUVECs and since the CD8 + T cells are exposed to HCMV-infected HUVECs along with uninfected HUVECs for 3 days in TKA, we hypothesize that CD8 + T cells partially become activated in TKA during the 3-day incubation, even though they do not get activated in the activation assay on exposure to uninfected HUVECs.
The generation of antigen-specific T cells from naïve T cells requires around 14 days of exposure to APCs in vivo [62] . We could observe the activation of naïve T cells occurring from 24 h after contact with infected HUVECs. We stained for the presence of T cells expressing activating NK receptors. Among the different NK receptors expressed on T cells [63, 64] , we stained for NKG2D. It has been shown already that NKG2D could activate antigen-specific T cells and behave like a co-stimulatory molecule [65] . In addition, the importance of NKG2D has gained attention in a recent publication where the HCMV strain expressing the host ligand ULBP2 for the NKG2D receptor was found to be susceptible for the control by effector cells [66] . More than 90 % of naïve CD8
+ T cell population from cord blood express NKG2D whereas only 3 % of CD4 + T cells express NKG2D. Therefore, we hypothesize that the naïve CD8 + T cells from cord blood respond more than CD4 + T cells. In our study, we could demonstrate that NKG2D could activate the naïve T cells. This was shown by staining and blocking the NKG2D receptor on the T cells. NKG2D seems to be the relevant receptor for the activation of the naïve T cells by HCMV-infected HUVECs since the activation was completely inhibited by blocking NKG2D on purified T cells.
CD4
+ T cells and CD8 + T cells were exposed to HCMV-infected and uninfected HUVECs for 3 days and later TKA was done along with positive and negative controls to quantify their inhibitions of HCMV transmission. Error bars represent the SD from two different donors. Table 1 . Slope values of experiments from Fig. 5(a) In the absence of classical APCs, the activation on exposure to HCMV-infected HUVECs happened only in the naïve CD8 + T cell population. When the NKG2D receptor is blocked, the activation of CD8 + T cells on exposure to HCMV-infected HUVECs both in the presence and absence of APCs is completely inhibited. The activation of CD4 + T cells is not inhibited by blocking NKG2D in the presence of APCs. This might be explained by other activation pathways by APCs which could be the reason for differential inhibition of activation of T cells in the presence and absence of APCs. Therefore, taking all these results, we hypothesize that there is some specific interaction between the ligands expressed on HCMV-infected HUVECs and the NKG2D receptor on naïve CD8 + T cells from CB.
MICA, MICB, ULBP1, ULBP2, ULBP3, ULBP4, ULBP5 and ULBP6 are the ligands expressed on target cells for NKG2D interaction [67, 68] . We showed two possible ligands that are expressed on HCMV-infected HUVECs which could be the interaction partners of the NKG2D receptor. It has been shown that HCMV UL16 gene downregulates some of the ligands (MICB, ULBP1 and ULBP2) of the NKG2D receptor thereby reducing the NKG2D activation of T cells [69] [70] [71] . We also saw a quantitative difference in the percentage of activated T cells when using an HCMV UL16 stop mutant (TB40-BAC KL7 -SE-EGFPUL16stop) (Fig. S8 ). It has also been shown that HCMV genes UL142, US18 and US20 can downregulate MICA and ULBP3 during infection [72] [73] [74] .
The HUWFs and HUVECs behaved similarly during infection. 100 % IR was achieved using the same MOI and also a similar cytopathic effect was observed in both target cell types. Yet, the activation of naïve T cells happened only on exposure to infected HUVECs and not by infected HUWFs. This could be due to the differences in the ligands' expression on HUVECs and HUWFs. HCMV-infected HUWFs do not express and upregulate the NKG2D ligands unlike HCMV-infected HUVECs.
To conclude, our study shows that the naïve T cells especially CD8 + T cells can get activated even in the absence of classical APCs, through NKG2D on exposure to HCMVinfected HUVECs which control the HCMV transmission.
METHODS Cells
PBMCs were isolated from the UCB and cryopreserved as described previously [75, 76] . Cells used in all experiments were always obtained from seronegative donors. Pan-T cells (CD3 + ), CD4 + T cells, CD8 + T cells and B cells were isolated from PBMCs by negative selection (STEMCELL, Germany). Purity of the T cells and B cells was around 96-97 %. HUVECs were isolated from the umbilical vein by chymotrypsin treatment and cultured in endothelial basal medium (EBM) (Lonza, USA). The cells were seeded onto culture flasks coated with 0.1 % gelatin. HUVECs were passaged till passage 3 and cryopreserved. PBMCs, T cells and B cells were co-cultured with HUVECs for activation and transmission inhibition experiments in RPMI 'glutamax' (Gibco, Germany) supplemented with 0.1 g l À1 gentamycin, 30 mg 500 ml À1 endothelial growth factor (Fisher Scientific, USA), 5 U ml À1 heparin (Sigma-Aldrich, Germany) and 10 % human serum (HCMV negative, 56 C inactivated). HUWFs were isolated from the same cord as described before [77, 78] by scratching and culturing the Wharton jelly in Dulbecco's modified Eagle's medium (DMEM) supplemented with fibroblast growth factor (FGF) in a six-well plate after covering the jelly with cover slip. HUWFs started growing after 10 days and when confluent, the cells were passaged until passage 4 and cryopreserved. PBMCs or isolated naïve T cells were co-cultured with HUWFs in MEM-a supplemented with human serum (10 %) and FGF. Recombinant human IL-2 (R&D systems, Germany) was used at a concentration of 100 IU ml À1 for stimulation of T cells in transmission inhibition experiments as the internal positive control. Immunoglobulins for intravenous use (IgG, Gamunex Talecris Biotherapeutics, Germany) were purchased commercially and used at a 1 : 20 dilution immediately after the co-culture of infected and uninfected HUVECs as the positive control in the TKA. Live cell analysis was performed during the activation assay before FACS analysis on day 3. (1) For PBMCs which were exposed to HCMV-infected HUVECs it was 71 %. (2) For PBMCs which were exposed to uninfected HUVECs it was 87 %. (3) For CD4 + T cells which were exposed to HCMV-infected HUVECs it was 85 %. (4) For CD4 + T which were exposed to uninfected HUVECs it was 93 %. (5) For CD8 + T which were exposed to HCMVinfected HUVECs it was 74 %. (6) For CD8 + T which were exposed to uninfected HUVECs it was 87 %.
Preparation of viral stocks and infection of HUVECs HCMV strain TB40/E was propagated in HFFs. For preparation of virus stocks, infectious supernatants from HFF cultures were harvested at 5-7 days post-infection (p.i.) when most of the cells showed the cytopathic effect. The EBM was changed to MEM and incubated for 30 min before infecting HUVECs. MEM was removed and the cells were infected with fresh cell-free virus (titre around 10 7 p.f.u. ml
À1
) and incubated for 2 h. The virus suspension was removed and EBM medium was added. 100 % infected HUVECs were trypsinized on 2 days p.i. and frozen at À80 C for further experiments. For different IRs of HUVECs, the cell-free virus was titrated 2-or 10-fold on HUVECs to determine the virus inoculums required for a 10, 45, 60, 90 % IR. The determined titres were used to infect HUVECs to obtain different IRs. The IRs of HUVECs was always determined by IEA staining after thawing and seeding in 96-well plates. TB40-BAC KL7 -SE-EGFP-UL16stop was generated according to the markerless mutagenesis protocol of Tischer et al. [79] . In brief, a recombination fragment was generated by PCR from plasmid pEP-Kan-S with primers 5¢-GGCC TCGATCCATCCTGGGGAAACGTGGACGTTACACGG GTGATGTATTTCTATCTAGTACTACGAGAATGTGAC CGAAGGATGACGACGATAAGT-3¢ and 5¢-CCACGCC TKA seeding protocol 100 % HCMV-infected HUVECs which were frozen on 2 days p.i. were used as infecting cells. Infecting HUVECs were thawed, counted and seeded in fourfold dilution from 640 to 40 (640, 160 and 40) along with 20 000 uninfected HUVECs for 3 days. Purified T cells from different preparations (defined as effectors) were added in an effector to a target ratio of 1 : 2. Co-cultures were maintained for 3 days prior to FACS analysis (IEA staining) in order to determine the transmission and also the transmission inhibition by effector cells. The detailed protocol has been published earlier [43] .
Transwell cultures
Transwell inserts (1 µm pore; Greiner Bio-One, Germany) in 24-well plates were used for transwell experiments to keep effector cells (immune cells) separated from target cells (HUVECs or HUWFs).
Immunofluorescence
To detect viral antigens, cells were fixed with 80 % acetone and incubated with IEA antibodies (pUL122/123; ArgeneBiosoft, France) followed by staining with AF488-conjugated goat anti-mouse immunoglobulins (Molecular probes/Invitrogen, Germany). Nuclei were counterstained with DAPI (4¢, 6¢-diaminidino-2-phenylindole). The number of IEA and DAPI signals was determined in three frames per well with an automated counting feature of the Zeiss AxioVision microscope. The ratio of IEA-positive nuclei to total DAPI-positive nuclei gives the IR of the cells.
Flow cytometer Activation experiments
The following monoclonal antibodies (MAbs) were used: peridinin chlorophyll protein (PerCP)-Cy5.5-anti-CD3 (UCHT1), (PerCP)-Cy5.5-anti-CD4 (SK3), allophycocyanin (APC)-anti-CD45RA (HI100), phycoerythrin PE-anti-gdT (B1) (all from BioLegend, Germany), (PE)-anti-CD56 (B-A19) (from Immunotools, Germany), PE-anti-NKG2D (1D11), FITC-anti-CD69 (FN50) (from BD Biosciences, Germany), FITC-anti-CD71 (CY1G4), FITC-anti-CD40L (anti-CD154) (24-31), FITC-anti-OX40 (CD134) (Ber-ACT35) (from Biolegend, Germany), APC-anti-CD62L (LT-TD180) (from Immunotools, Germany) and FITCanti-CCR7 (150503) (BD Biosciences, Germany). Anti-CD3 and anti-CD4 antibodies were used in 1 : 20 and 1 : 2 (antibody: PBS) dilutions to differentiate the CD4 + and non-CD4 + population of CD3 + T cells. PBMCs and isolated T cells were surface stained with surface markers (CD3, CD4, CD45RA and CD69) for 45 min after co-culture (3 days) with infected or uninfected HUVECs (E:T=10 : 1). Phorbol 12-myristate 13-acetate (PMA) (10 ng ml
À1
) and ionomycin (1 µg ml
) were used as a positive control in the activation experiments.
IFN-g and IL-2 production assay After co-culture of effector and target cells, monensin (GolgiStop, 2 µM) (BD Biosciences, Germany) and brefeldin A (5 mg ml À1 ) (Sigma-Aldrich, Germany) were added to the cultures for the last 5 h. Then the effector cells were collected, stained with surface markers (CD3, CD4, CD45RA) for 45 min and then the cells were fixed and permeabilized (554715, BD Biosciences, cytofix and cytoperm). Finally the permeabilized cells were stained with PE-IFN-g (B27), FITC-anti-IL-2 (MQ17H12) (both from BioLegend, Germany). PMA and ionomycin were again used as a positive control and uninfected HUVECs were used as a negative control.
Counting of infected cells (TKA)
The effector cells in suspension were removed after 3 days of co-culture and the HUVECs were fixed and permeabilized after trypsinization by 4 % PFA and ice cold 80 % ethanol. The cells were stained for IEA (pUL122/123, Argene-Biosoft, France) followed by staining with Alexa flour 647-conjugated goat anti-mouse immunoglobulins (Molecular probes/Invitrogen, Germany) before analysing by FACS. Overall, 10000-15000 events were obtained for each sample.
NKG2D blocking
PBMCs and isolated T cells were incubated with NKG2D-blocking antibodies (LEAF purified anti-human CD314 antibody, BioLegend, Germany) (1D11) for 30 min and then co-cultured with HCMV-infected and uninfected HUVECs for 3 days. The immune effector cells were collected and stained for surface markers (CD3, CD4, CD45RA, CD69 and NKG2D) for 45 min before analysing by FACS.
represented in the dot plots in (a-d). One-way ANOVA test was first used, which gave significant variance in the group (Pvalue<0.0001). The t-test was performed as a post hoc test to examine the significance of inhibition of activation by NKG2D-blocking antibodies. P-values were 0.0169 (*) for the inhibition by NKG2D-blocking antibodies in the presence of APCs and 0.0035 (**) for the inhibition by NKG2D-blocking antibodies in the absence of APCs. Error bars represent the SD of data from three different donors. 
